Welcome to LookChem.com Sign In|Join Free

CAS

  • or

12700-20-8

Post Buying Request

12700-20-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

12700-20-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 12700-20-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,2,7,0 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 12700-20:
(7*1)+(6*2)+(5*7)+(4*0)+(3*0)+(2*2)+(1*0)=58
58 % 10 = 8
So 12700-20-8 is a valid CAS Registry Number.

12700-20-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]-3-phenylmethoxypropanoate,gadolinium(3+),hydron,(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:12700-20-8 SDS

12700-20-8Upstream product

12700-20-8Downstream Products

12700-20-8Related news

Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: Comparison of GADOBENATE DIMEGLUMINE (cas 12700-20-8) and gadofosveset trisodium08/30/2019

Rationale and objectivesDedicated contrast agents are now available for contrast-enhanced magnetic resonance angiography (CE-MRA). This study retrospectively compares the safety and diagnostic performance data from Phase III regulatory trials performed to evaluate gadobenate dimeglumine (MultiHa...detailed

Non-clinical assessment of safety and gadolinium deposition after cumulative administration of GADOBENATE DIMEGLUMINE (cas 12700-20-8) (MultiHance®) to neonatal and juvenile rats08/29/2019

To determine the impact of single and cumulative doses of MultiHance on toxicity, pharmacokinetics, tissue gadolinium presence, behavior and neurological function in juvenile rats. Juvenile male and female rats received either physiological saline or MultiHance at 0.6, 1.25 or 2.5 mmol/kg bodywe...detailed

Original contributionImproved coronary magnetic resonance angiography using GADOBENATE DIMEGLUMINE (cas 12700-20-8) in pediatric congenital heart disease08/28/2019

BackgroundCMRA in pediatrics remains challenging due to the smaller vessel size, high heart rates (HR), potential image degradation caused by limited patient cooperation and long acquisition times. High-relaxivity contrast agents have been shown to improve coronary imaging in adults, but limited...detailed

Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of GADOBENATE DIMEGLUMINE (cas 12700-20-8) and 0.1 mmol/kg of gadoterate meglumine for cranial MRI08/27/2019

PurposeTo retrospectively compare a reduced dose (RD) (0.075 mmol/kg) of gadobenate dimeglumine (RD-gadobenate) with standard single dose (SSD) (0.1 mmol/kg) of gadoterate meglumine (SSD-gadoterate) for cranial MRI.detailed

Quantitative and qualitative comparison of 0.025 mmol/kg GADOBENATE DIMEGLUMINE (cas 12700-20-8) for abdominal MRI at 1.5 T and 3 T MRI in patients with low estimated glomerular filtration rate08/26/2019

PurposeTo investigate the efficacy and adequacy of enhancement employing 0.025 mmol/kg of gadobenate dimeglumine at 1.5 Tesla (T), and to compare the extent of enhancement of this dosage between 1.5 T and 3 T systems.detailed

Original articleComparison of gadofosveset (Vasovist®) with GADOBENATE DIMEGLUMINE (cas 12700-20-8) (Multihance®)-enhanced MR angiography for high-grade carotid artery stenosis08/23/2019

SummaryObjectiveTo prove superiority of blood pool contrast agent gadofosveset over conventional contrast agent gadobenate dimeglumine for assessment of stenotic internal carotid artery (ICA).detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 12700-20-8